Qumis | $2,200,000 | (Jan 22, 2025)
ExSURE PVT. LTD. | $347,401 | (Jan 22, 2025)
Belfry | $12,000,000 | (Jan 22, 2025)
Certified by Founder
Lodge
Psylo
start up
Australia
- Sydney, NSW
- 04/06/2024
- Seed
- $8,000,000
Psylo is a drug development company focused on next generation psychedelics; our goal is to make broadly accessible medicines as improved treatments to currently available SSRI medications, using psychedelic molecules as the starting point. We are building a pipeline of novel molecules with the ultimate goal of taking leading candidates through to clinical trials.
- Industry Biotechnology
- Website https://psylo.bio/
- LinkedIn https://www.linkedin.com/company/psylo/
Gravity(US) | $13,000,000 | (Jan 22, 2025)
LeapXpert | $20,000,000 | (Jan 22, 2025)
BPR Hub | $2,600,000 | (Jan 22, 2025)
NovoLINC | Undisclosed Amount | (Jan 22, 2025)
Percipio Health | $20,000,000 | (Jan 22, 2025)
Zynap | $5,937,902 | (Jan 22, 2025)
Highnote | $90,000,000 | (Jan 22, 2025)
IntusCare | $11,500,000 | (Jan 21, 2025)
ecoplanet | $16,571,680 | (Jan 21, 2025)